(ST012) DNA damage response gene expression profile distinguishes poor-acting IDH-mutant gliomas with shared methylome signatures.

Friday, November 17, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Nalin Leelatian, MD, PhD

Clinical Fellow, Molecular Genetic Pathology
University of North Carolina School of Medicine
Chapel Hilll, North Carolina, United States